You are here:
NICE
NICE Guidance
Conditions and diseases
Eye conditions
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration
Technology appraisal guidance
Reference number:
TA155
Published:
27 August 2008
Last updated:
20 May 2024
Guidance
Tools and resources
Information for the public
History
Research recommendations coming out of this guidance
There are no research recommendations for TA155